๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Angiogenic gene therapy: pre-clinical studies and phase I clinical data

โœ Scribed by Bashir, Riyaz; Vale, Peter R.; Isner, Jeffrey M.; Losordo, Douglas W.

Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
62 KB
Volume
61
Category
Article
ISSN
0085-2538

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Gene therapy for pain: Results of a phas
Gene therapy for pain: Results of a phase I clinical trial
โœ David J. Fink; James Wechuck; Marina Mata; Joseph C. Glorioso; James Goss; David ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 235 KB ๐Ÿ‘ 2 views

## Abstract ## Objective: Preclinical evidence indicates that gene transfer to the dorsal root ganglion using replicationโ€defective herpes simplex virus (HSV)โ€based vectors can reduce painโ€related behavior in animal models of pain. This clinical trial was carried out to assess the safety and explo

Gene transfer and therapy clinical trial
Gene transfer and therapy clinical trials โ€“ update. Part I: Countries, Diseases, Clinical trial phases, Routes of administration
โœ Thomas Valรจre ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 183 KB ๐Ÿ‘ 2 views

Part I\*: Countries, Diseases, Clinical trial phases, Routes of administration ## Countries Countries where clinical trials are being performed or have been approved Gene therapy trials have now been initiated on all ยฎve continents but the large majority of trials are being performed in the USA

An inventory of shedding data from clini
An inventory of shedding data from clinical gene therapy trials
โœ Ellen A. M. Schenk-Braat; Marjolein M. K. B. van Mierlo; Gerard Wagemaker; Chris ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 172 KB

## Abstract Viruses are the most commonly used vectors for clinical gene therapy. The risk of dissemination of a viral vector into the environment via excreta from the treated patient, a phenomenon called shedding, is a major safety concern for the environment. Despite the significant number of cli

Guidelines for the design and implementa
Guidelines for the design and implementation of clinical studies in somatic cell therapy and gene therapy
โœ A. Lindemann; F. M. Rosenthal; R. Mertelsmann; S. Hase; P. Markmeyer ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Springer ๐ŸŒ English โš– 443 KB

According to Sects. 2 and 3 of the German drug statute, (Arzneimittelgesetz, AMG) gene technology and gene therapy products as well as somatic cell therapy products are regarded as drugs and are therefore subject to Sects. 40 and 41, stipulating the requirements for clinical studies designed to test